R&D of Vaccines Driving Demand for Transfection Reagents and Equipment

San Francisco, California, July 07, 2017 : The growing need for protein production, research and development of vaccines, and the advancement in the biopharmaceutical sector are some of the primary drivers of the global transfection reagents and equipment market, according to a report by TMR Research. The report, titled “Transfection Reagents and Equipment Market – Global Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 – 2025,” has been prepared to serve as reliable business tool for stakeholders such as biopharmaceutical companies, biotechnology companies, transfection equipment, reagent, and kit manufacturing companies, suppliers and distributors of transfection reagents, research institutes, academic centers, and venture capitalists. The report segments the global transfection reagents and equipment market into smaller segments of various aspects such as product, end-users, method, application, and region, provides in-depth assessment of the factors that may impact the demand in the near future, and profiles a number of leading companies operating in this market in order to gauge the competitive landscape.

As per the findings of the report, the advancements in transfection technology such as Crispr-Cas9, Car-T, and three dimension (3D) transfection technology bode very well for the future of the transfection reagents and equipment market, which will also gain traction from factors such as alliances among the leading research institutes in order to formulate drugs, increase in investment for research and development by pharmaceutical and biotechnology companies, incremented research activities in cell science, growing demand for synthetic genes, and the prevalence of cancer. On the other hand, factors such as home brew reagents, selective effectiveness of transfection reagents, and high cost of these reagents are hindering the market from attaining its true potential.

Based on method, the global transfection reagents and equipment market can be segmented into biochemical, DEAE-dextran, calcium, phosphate, dendrimers, lipofection, physical, nucleofection, electroporation, viral, and others including sonoporation, genegun, optoinjection, and magnetofection. Application-wise, the market can be categorized into biomedical research, gene expression studies, cancer research, transgenic model, therapeutic delivery, and protein production. Geographically, the report assess the potential of transfection reagents and equipment market in all the important regions such as North America, Europe, and Asia Pacific. Currently, North America is most lucrative region, owing to the headquarters of a number of leading players in the U.S., while Asia Pacific is also expected to increment the demand at a robust rate during to considerable growth of cytological research and the development of biosimilar drugs in the region.

As far as competitive landscape of the global transfection reagents and equipment market is concerned, only a few companies lead, with Thermo Fisher Scientific Inc., Promega, and Roche ahead of the curve, strengthening their position via strategic business expansion, consolidation, and acquisition. Bio-Rad Laboratories Inc., SignaGen Laboratories, EMD Millipore, Harvards Apparatus Inc., OriGene Technologies, Mirus Bio LLC, Lonza AG, Qiagen, and VWR International LLC are some of the other key vendors operating in this market.